Literature DB >> 31688589

Drug-Induced Acute Pancreatitis in Adults: An Update.

C Roberto Simons-Linares1, Mohamed A Elkhouly2, Miguel J Salazar2.   

Abstract

Drug-induced acute pancreatitis (DIAP) is a rare entity that is often challenging for clinicians. The aim of our study was to provide updated DIAP classes considering the updated definition of acute pancreatitis (AP) and in light of new medications and new case reports. A MEDLINE search (1950-2018) of the English language literature was performed looking for all adult (≥17 years old) human case reports with medication/drug induced as the cause of AP. The included case reports were required to provide the name of the drug, and diagnosis of AP must have been strictly established based on the revised Atlanta Classification criteria. A total of 183 medications were found to be implicated in 577 DIAP cases. A total of 78 cases were excluded because of minimal details or lack of definite diagnosis of AP. Drug-induced AP is rare, and most drugs cause mild DIAP. Only 2 drugs are well described in the literature to explain causation rather than association (azathioprine and didanosine). Larger case-control studies and a formal standardized DIAP reporting system are essential to study the true potential of the DIAP-implicated drugs described in this review.

Entities:  

Mesh:

Year:  2019        PMID: 31688589     DOI: 10.1097/MPA.0000000000001428

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  10 in total

1.  Case Report: Azathioprine: An Old and Wronged Immunosuppressant.

Authors:  Pedro R Chocair; Precil Diego Miranda de Menezes Neves; Sara Mohrbacher; Maurilio Pacheco Neto; Victor A H Sato; Érico S Oliveira; Leonardo V Barbosa; Alessandra M Bales; Fagner Pereira da Silva; Américo L Cuvello-Neto; John A Duley
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

2.  Cohort profile: the Swedish Pancreatitis Cohort (SwePan).

Authors:  Daniel Selin; Bei Yang; Mats Lindblad; Urban Arnelo; Magnus Nilsson; Omid Sadr-Azodi; John Maret-Ouda
Journal:  BMJ Open       Date:  2022-05-27       Impact factor: 3.006

3.  Clinical Outcomes and Inpatient Mortality Among Hospitalized Patients With Concomitant Autoimmune Hepatitis and Systemic Lupus Erythematosus.

Authors:  Ahmed M Ahmed; Sarthak R Patel; Yasir R Rajwana; Robert Spira
Journal:  Cureus       Date:  2022-05-13

4.  A Case of Carbamazepine-Induced Acute Pancreatitis: A Rare Etiology.

Authors:  Asim Ali; Gibson O Anugwom; Warda Naqvi; Mohammad Omar Saeeduddin; Romil Singh
Journal:  Cureus       Date:  2021-05-23

5.  Empagliflozin-Associated Pancreatitis: A Consideration for SGLT2 Inhibitors.

Authors:  Karolina N Dziadkowiec; Peter M Stawinski; Jose Proenza
Journal:  ACG Case Rep J       Date:  2021-01-19

6.  Another Case of Lisinopril-Induced Acute Pancreatitis.

Authors:  Jeffrey Baum; Aaron Walfish; Moshe Fenster; Yair Miller; Mindy Kresch
Journal:  Cureus       Date:  2021-11-11

7.  Case Report: Acute Pancreatitis Associated With Tacrolimus in Kidney Transplantation and a Review of the Literature.

Authors:  Yixuan Ding; Chang Qu; Huan He; Feng Cao; Tongwen Ou; Fei Li
Journal:  Front Med (Lausanne)       Date:  2022-04-21

Review 8.  Systematic review-pancreatic involvement in inflammatory bowel disease.

Authors:  Sara Massironi; Ilaria Fanetti; Chiara Viganò; Lorena Pirola; Maria Fichera; Laura Cristoferi; Gabriele Capurso; Pietro Invernizzi; Silvio Danese
Journal:  Aliment Pharmacol Ther       Date:  2022-05-03       Impact factor: 9.524

9.  An Uncommon Cause of Acute Pancreatitis in a Patient With COVID-19.

Authors:  Francisco Vara-Luiz; Fábio Pé D'Arca Barbosa; Ana Antunes Albuquerque; Ana Valada Marques; Vanda Spencer
Journal:  Cureus       Date:  2022-08-12

10.  The Risk of Acute Pancreatitis and Selective Serotonin Reuptake Inhibitors Use: A Meta-Analysis of Case-Control Studies.

Authors:  Shih-Wei Lai; Cheng-Chan Yu; Cheng-Li Lin; Kuan-Fu Liao
Journal:  Dose Response       Date:  2020-03-30       Impact factor: 2.658

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.